Divalproex Sodium Tablet, Delayed Release
Product Images NDC 71335-0008

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 71335-0008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

39cef9df 868d 4963 B0a7 7f146275442f 01

FDA Label Image

39cef9df 868d 4963 B0a7 7f146275442f 02

FDA Label Image

39cef9df 868d 4963 B0a7 7f146275442f 03

FDA Label Image

39cef9df 868d 4963 B0a7 7f146275442f 04

FDA Label Image

39cef9df 868d 4963 B0a7 7f146275442f 05

FDA Label Image

39cef9df 868d 4963 B0a7 7f146275442f 06

FDA Label Image

Label Image (Lbl713350008)

This is a prescription drug label for Divalproex, a medication to treat seizures, bipolar disorder, and migraine headaches. It's a pink oval tablet with a strength of 250mg. The medication should be stored at room temperature and kept out of reach of children. The label includes information on quantity, expiration date, and a unique identification number (NDC).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.